Cargando…
Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
BACKGROUND: The prevalence of gastroesophageal reflux disease (GERD) has had a marked increase in Western countries with a paralleling interest in extraesophageal (EE) manifestations of GERD, including laryngopharyngeal reflux (LPR). There are considerable differences in clinical practice between ga...
Autores principales: | Fossmark, Reidar, Ness-Jensen, Eivind, Sørdal, Øystein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483799/ https://www.ncbi.nlm.nih.gov/pubmed/37674110 http://dx.doi.org/10.1186/s12876-023-02945-7 |
Ejemplares similares
-
Investigation of extraesophageal gastroesophageal reflux disease
por: Tsoukali, Emmanouela, et al.
Publicado: (2013) -
Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?
por: Aasarød, Kristin M., et al.
Publicado: (2021) -
Prevalence of Extraesophageal Symptoms in Patients With Gastroesophageal Reflux Disease: A Multicenter Questionnaire-based Study in Korea
por: Min, Yang Won, et al.
Publicado: (2014) -
Gastroesophageal reflux disease: prevalence and Extraesophageal manifestations among undergraduate students in South West Nigeria
por: Akinola, Moses Ayodele, et al.
Publicado: (2020) -
Metabolomic profiling of extraesophageal reflux disease in children
por: Mahoney, Lisa B., et al.
Publicado: (2021)